Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine

Journal of Pediatrics

Volumn 128, Issue 4, 1996, Pages 524-530

  Kurikka, S ^a   Kayhty, H ^a   Saarinen, L ^a   Ronnberg, P R ^a   Eskola, J ^a   Makela, P H ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INACTIVATED VACCINE; POLIOMYELITIS VACCINE;

ARTICLE; BACTERIAL INFECTION; HUMAN; IMMUNOGENICITY; INFANT; INFECTION PREVENTION; NORMAL HUMAN; PRIORITY JOURNAL; TREATMENT PLANNING; VACCINATION;

EID: 0029989285     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(96)70364-5     Document Type: Article

References (32)

1. N Halsey A. Galazka The efficacy of DTP and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age Bull World Health Organ 63 1985 1151 1169
2. Vaccine demand and supply VS Mitchell NM Philipose JP Sanford The children's vaccine initiative: achieving the vision 66 1993 National Academy Press Washington, D.C 194 195
3. B Aylward M Kane A Batson R. McNair Scott A framework for the evaluation of vaccines for use in the expanded programme on immunization Vaccine 12 1994 1155 1159
4. DA Clemens R Booy R Dagan Comparison of the epidemiology and cost of Haemophilus influenzae type b disease in five western countries Pediatr Infect Dis J 12 1993 362 367
5. LJ Baraff RD Leake DG Burstyn Immunological response to early and routine DTP immunization in infants Pediatrics 73 1984 37 42
6. RS Munson MH Kabeer AA Lenoir DM Granoff Epidemiology and prospects for prevention of disease due to Haemophilus influenzae in developing countries Rev Infect Dis 11 suppl 3 1992 588 597
7. PH Mäkelä H Peltola H Käyhty Polysaccharide vaccines of group A Neisseria meningitidis and Haemophilus influenzae type b: a field trial in Finland J Infect Dis 190 suppl 1977 43 50
8. RS. Baltimore New challenges in the development of a conjugate pneomococcal vaccine JAMA 268 1992 3366 3367
9. H Campbell P Byass VI Ahonkhai PP Vella BM Greenwood Serologic responses to an Haemophilus influenzae type b- Neisseria meningitidis outer membrane protein conjugate vaccine in very young Gambian infants Pediatrics 86 1990 102 107
10. 197 conjugate vaccine in 1- to 6-month-old infants Pediatrics 85 1990 331 337
11. S Kurikka H Käyhty H Peltola L Saarinen J Eskola PH Mäkelä Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine Pediatrics 95 1995 815 822
12. C Ferreccio J Clemens A Avendano The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age Pediatr Infect Dis J 10 1991 764 771
13. R Gold D Scheifele L Barreto Safety and immunogenicity of Haemophilus influenzae (tetanus toxoid conjugate) administered concurrently with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age Pediatr Infect Dis J 13 1994 348 355
14. R Dagan C Botujansky N Watemberg Safety and immunogenicity in young infants of Haemophilus b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis-enhanced inactivated poliovirus vaccine Pediatr Infect Dis J 13 1994 356 361
15. N Watemberg R Dagan Y Arbelli Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants Pediatr Infect Dis J 10 1991 758 761
16. SL Kaplan BA Lauer MA Ward Immunogenicity and safety of Haemophilus influenzae type b-tetanus protein conjugate vaccine alone mixed with diphtheria-tetanus-pertussis vaccine in infants J Pediatr 124 1994 323 327
17. H Sarvas I SeppAdalä S Kurikka R Siegberg O Mäkelä Half-life of the maternal IgG1 allotype in infants J Clin Immun 13 1993 145 151
18. J Eskola H Käyhty LK Gordon Simultaneous administration of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood Pediatr Infect Dis J 7 1988 480 484
19. P Anderson M Pichichero K Edwards CR Porch R Insel Priming and induction of Haemophilus influenzae type b capsular antibodies in early infancy by Dpo20, an oligosaccharide-protein conjugate vaccine J Pediatr 111 1987 644 650
20. EK Mulholland VI Ahonkhai AM Greenwood Safety and immunogenicity of Haemophilus influenzae type b- Neisseria meningitidis group B outer membrane protein complex conjugate vaccine mixed in the syringe with diptheria-tetanus-pertussis vaccine in young Gambian infants Pediatr Infect Dis J 12 1993 632 637
21. DM Granoff SJ Holmes R Belshe MT Osterholm JE McHugh EL Anderson Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants JAMA 272 1994 1116 1121
22. A Avendano C Ferreccio R Lagos Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age Pediatr Infect Dis J 12 1993 638 643
23. 197 protein vaccines in infancy Arch Pediatr Adolesc Med 148 1994 620 625
24. J Eskola A Takala H Käyhty H Peltola PH Mäkelä Experience in Finland with Haemophilus influenzae type b vaccines Vaccine 9 suppl 1991 14 16
25. T Barington A Gyhrs K Kristensen C Heilman Opposite effects of actively and passively acquired immunity to the carrier on responses of human infants to a Haemophilus influenzae type b conjugate vaccine Infect Immun 62 1994 9 14
26. BA Claesson R Schneerson JB Robbins Protective levels of serum antibodies stimulate in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate J Pediatr 114 1989 97 100
27. JC Parke R Schneerson C Reimer Clinical and immunologic response to Haemophilus influenzae type b-tetanus toxoid conjugate at 3, 5, 7, and 18 months of age J Pediatr 118 1991 184 190
28. DM Granoff SJ Holmes MT Osterblom Induction of immunological memory in infants primed with Haemophilus influenzae type b conjugate vaccine J Infect Dis 168 1993 663 671
29. R Booy S Hodgson L Carpenter Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T Lancet 344 1994 362 366
30. J Eskola H Käyhty AK Takala A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease N Engl J Med 323 1990 1381 1387
31. H Käyhty J Eskola H Peltola L Saarinen PH Mäkelä High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines J Infect Dis 165 suppl 1 1992 165 166
32. H Peltola T Kilpi M Anttila Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines Lancet 340 1993 592 594